STXBP3

STXBP3 (Munc18c/MUNC18-3) is a syntaxin-binding protein that regulates intracellular vesicular trafficking and regulated exocytosis (PMID:18556422). In secretory enterochromaffin cells it controls vesicle docking and serotonin release, with loss of STXBP3 reducing 5-HT secretion (PMID:18556422), and in epithelial cells it is required for normal cell polarity, where reduced STXBP3 expression produces polarity defects (PMID:33891011). Although structurally related to MUNC18-1, STXBP3 lacks the hydrophobic β-sheet 10 residue corresponding to V263 and therefore cannot restore the submembrane F-actin network in Munc18-1-KO chromaffin cells; introducing a hydrophobic residue at that position confers F-actin regulatory activity, establishing that this residue governs F-actin organization independently of syntaxin1 targeting (PMID:31719162).

1. 2008 Medium

   Established that STXBP3 acts in regulated secretion by controlling secretory vesicle docking/exocytosis, defining its functional role in a secretory cell type.

   Evidence Antisense knockdown in neoplastic enterochromaffin cells (KRJ-I) with serotonin secretion assay

   PMID:18556422

   Open questions at the time

   • Single method without reciprocal/biochemical validation of the docking step
   • Direct syntaxin partner in EC cells not identified
   • No structural basis for the docking activity established
2. 2019 Medium

   Resolved why STXBP3 diverges functionally from MUNC18-1, mapping F-actin regulatory capacity to a single β-sheet 10 hydrophobic residue distinct from syntaxin targeting.

   Evidence Mutagenesis of STXBP3 expressed in Munc18-1-KO mouse chromaffin cells with F-actin network imaging

   PMID:31719162

   Open questions at the time

   • Physiological relevance of STXBP3 lacking native F-actin activity not addressed
   • Molecular mechanism linking the residue to F-actin remodeling not dissected
   • Endogenous role of this residue in STXBP3-expressing cell types unknown
3. 2021 Medium

   Linked STXBP3 loss-of-function to epithelial cell polarity, extending its trafficking role beyond regulated secretion and connecting it to human disease variants.

   Evidence Whole exome/Sanger sequencing of variants, Western blot for protein stability, and siRNA knockdown in CaCo2 cells with cell polarity readout

   PMID:33891011

   Open questions at the time

   • Molecular pathway connecting STXBP3 to polarity machinery not defined
   • Causality of variants in patient phenotype not established by rescue
   • Trafficking cargo affected in epithelial cells not identified
4. 2025 Low

   Implicated STXBP3 in SNARE-mediated membrane fusion underlying extracellular vesicle secretion, broadening its trafficking remit to EV biogenesis.

   Evidence Genome-wide CRISPR activation screen for CD63 surface levels with genomic activation/ablation and proteomics (preprint)

   PMID:bio_10.1101_2025.07.24.665424

   Open questions at the time

   • Mechanistic role of STXBP3 itself not directly dissected; identified as a screen collaborator
   • Single preprint, not peer-reviewed or independently confirmed
   • Direct interaction with MARCKSL1 or the SNARE machinery not validated biochemically

• How STXBP3 selects specific syntaxin partners and coordinates docking across distinct cell types (secretory, epithelial, EV-secreting) remains unresolved.
• No defined syntaxin/SNARE binding partner identified in the timeline
• No structural model of STXBP3-SNARE complexes
• Unified mechanism reconciling secretion, polarity, and EV roles not established